Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Petiq Inc Cl A (PETQ)

Petiq Inc Cl A (PETQ)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 873,039
  • Shares Outstanding, K 28,272
  • Annual Sales, $ 528,610 K
  • Annual Income, $ -780 K
  • 60-Month Beta 1.94
  • Price/Sales 1.03
  • Price/Cash Flow 25.36
  • Price/Book 2.58

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate 0.09
  • Number of Estimates 4
  • High Estimate 0.12
  • Low Estimate 0.05
  • Prior Year 0.06
  • Growth Rate Est. (year over year) +50.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
24.08 +28.24%
on 01/09/20
31.64 -2.40%
on 01/16/20
+4.92 (+18.95%)
since 12/24/19
3-Month
21.28 +45.11%
on 11/11/19
31.64 -2.40%
on 01/16/20
+5.82 (+23.22%)
since 10/24/19
52-Week
21.28 +45.11%
on 11/11/19
36.33 -15.00%
on 07/23/19
+2.58 (+9.12%)
since 01/24/19

Most Recent Stories

More News
Perrigo (PRGO) Rises on Stellar Q419 Preliminary Results

Perrigo (PRGO) announces better-than-expected preliminary results for fourth-quarter 2019 as well as the full year. Shares gain.

PRGO : 58.76 (-1.21%)
EXAS : 89.57 (-2.83%)
DNLI : 24.65 (-1.00%)
PETQ : 30.88 (+0.52%)
PetIQ, Inc. Provides Update on Wellness Center Openings

Celebrated 20 Wellness Center Openings in December

PETQ : 30.88 (+0.52%)
PetIQ, Inc. Enters Into Definitive Agreement to Acquire the Capstar(R) portfolio of products from Elanco

PetIQ, Inc. ("PetIQ" or the "Company") (Nasdaq: PETQ), a leading pet medication and wellness company, and Elanco today announced they have executed a definitive agreement under which PetIQ will acquire...

PETQ : 30.88 (+0.52%)
ELAN : 31.57 (-2.11%)
Elanco Signs Agreement with PetIQ to Divest Capstar(R)

Elanco Animal Health Incorporated (NYSE: ELAN) announced today it signed an agreement to divest the U.S. rights to Capstar(R), an oral tablet that kills fleas in dogs and cats, to PetIQ, Inc. (Nasdaq:...

BAYRY : 20.8000 (-3.66%)
PETQ : 30.88 (+0.52%)
BAYN : 0.0147 (unch)
ELAN : 31.57 (-2.11%)
PetIQ, Inc. to Participate in the 2020 ICR Conference

PetIQ, Inc. ("PetIQ" or the "Company") (Nasdaq: PETQ), a leading pet medication and wellness company, today announced that the executive management team, including Cord Christensen, Chairman and CEO, and...

PETQ : 30.88 (+0.52%)
PetIQ, Inc. Provides Update on Wellness Center Openings

Celebrated 34 Wellness Center Openings in November

PETQ : 30.88 (+0.52%)
PetIQ, Inc. Reports Record Third Quarter 2019 Financial Results

Third Quarter 2019 Net Sales Increased 42% Year-Over-Year to $186 Million

PETQ : 30.88 (+0.52%)
Perrigo (PRGO) Beats on Q3 Earnings, Tightens '19 EPS View

Perrigo (PRGO) reports mixed third-quarter 2019 results. The Rx segment continues to witness recovery. Stock down.

PRGO : 58.76 (-1.21%)
ACOR : 2.10 (-11.39%)
VRTX : 229.06 (-2.07%)
PETQ : 30.88 (+0.52%)
What's in the Cards for Perrigo (PRGO) This Earnings Season?

Perrigo's (PRGO) Consumer Self Care Americas segment is expected to have aided the company's top line in the soon-to-be reported quarter.

GSK : 47.23 (-1.23%)
PRGO : 58.76 (-1.21%)
AMRN : 20.22 (-2.60%)
PETQ : 30.88 (+0.52%)
PetIQ, Inc. to Participate in the Credit Suisse Healthcare Conference

PetIQ, Inc. ("PetIQ" or the "Company") (Nasdaq: PETQ), a leading pet medication and wellness company, today announced that the executive management team will participate in the 28 Annual Credit Suisse...

PETQ : 30.88 (+0.52%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Average short term outlook on maintaining the current direction.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade PETQ with:

Business Summary

PetIQ, Inc. is a pet medication and wellness company. Its product consists of Rx Medications, OTC Medications and Supplies, Health and Wellness Products. The Company serves retail stores across the mass, club, grocery, pharmacy and e-commerce channels. PetIQ, Inc. is based in Eagle, United States.

See More

Key Turning Points

2nd Resistance Point 31.59
1st Resistance Point 31.24
Last Price 30.88
1st Support Level 30.41
2nd Support Level 29.93

See More

52-Week High 36.33
Last Price 30.88
Fibonacci 61.8% 30.58
Fibonacci 50% 28.81
Fibonacci 38.2% 27.03
52-Week Low 21.28

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar